COMPARISON OF ORAL ISOSORBIDE AND INTRAVENOUS MANNITOL AS ADJUNCTS TO DIURESIS OF PATIENTS WITH CIRRHOSIS OF LIVER

被引:8
作者
GAGNON, O
GERTMAN, PM
IBER, FL
机构
关键词
D O I
10.1097/00000441-196709000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:284 / &
相关论文
共 50 条
[31]   A comparison of an open and laparoscopic appendectomy for patients with liver cirrhosis [J].
Tsugawa, K ;
Koyanagi, N ;
Hashizume, M ;
Tomikawa, M ;
Ayukawa, K ;
Akahoshi, K ;
Sugimachi, K .
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2001, 11 (03) :189-194
[32]   Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients [J].
Wu, ZG ;
Li, JN ;
Fan, M ;
Shang, YK ;
Zhang, YW ;
Bai, J ;
Ding, R ;
Cheng, JM ;
Chun, LA .
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (05) :275-279
[33]   EFFECT OF PERORAL ADMINISTRATION OF ISOSORBIDE DINITRATE ON PORTAL PRESSURE AND BLOOD-FLOW IN PATIENTS WITH CIRRHOSIS OF THE LIVER [J].
CERVINKA, J ;
KORDAC, V ;
KALAB, M .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1989, 17 (06) :560-564
[34]   Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes [J].
Kyle A. Davis ;
Joel Joseph ;
Sarah A. Nisly .
Journal of Thrombosis and Thrombolysis, 2020, 50 :457-461
[35]   Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes [J].
Davis, Kyle A. ;
Joseph, Joel ;
Nisly, Sarah A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) :457-461
[36]   Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine [J].
Bae, SK ;
Lee, SJ ;
Lee, JY ;
Lee, Y ;
Lee, I ;
Sang, SG ;
Lee, MG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :227-238
[37]   Heparin solution for locking intravenous infusion devices in decompensated liver cirrhosis patients [J].
Wang, Rui ;
Zhang, Ming-Guang ;
Luo, Yan-Li .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 :181-182
[38]   Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis [J].
Schneiter, P ;
Gillet, M ;
Chioléro, R ;
Jéquier, E ;
Tappy, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (10) :1260-1266
[39]   ORAL DISPOSITION KINETICS OF OFLOXACIN IN PATIENTS WITH COMPENSATED LIVER-CIRRHOSIS [J].
ORLANDO, R ;
SAWADOGO, A ;
MIGLIOLI, PA ;
CAPPELLAZZO, MG ;
PALATINI, P .
CHEMOTHERAPY, 1992, 38 (01) :1-6
[40]   ORAL CAFFEINE CLEARANCE IN PATIENTS WITH LIVER-CIRRHOSIS OF VARIOUS ETIOLOGIES [J].
JOERES, R ;
BRACHTEL, D ;
GALLENKAMP, H ;
HOFSTETTER, G ;
KLINKER, H ;
ZILLY, W ;
RICHTER, E .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (01) :40-40